Wanbury Ltd - WANBURY Share Price

Sector: Pharmaceuticals | ISIN: INE107F01022
₹ 159.60 (1.98%) icon23 Feb, 2024, 12:00:00 AM
Open
₹ 159.60
Prev. Close
₹ 156.50
Turnover(lac)
₹ 0.00
Day's High
₹ 159.60
Day's Low
₹ 159.60
52 Wk High
₹ 164.10
52 Wk Low
₹ 33.30
Book Value
₹ 4.58
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 522.62
P/E
21.85
EPS
7.31
Div. Yield
0.00

Wanbury Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/23/2024 12:00:00 AM

    ₹ 159.6 3.10 1.98
  • Open
  • ₹ 159.6
  • Prev. Close
  • ₹ 156.5
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 159.6
  • Day's Low
  • ₹ 159.6
  • 52 Week's High
  • ₹ 164.1
  • 52 Week's Low
  • ₹ 33.3
  • Book Value
  • ₹ 4.58
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 522.62
  • P/E
  • 21.85
  • EPS
  • 7.31
  • Divi. Yield
  • 0

Wanbury Ltd Corporate Actions

12 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Jan , 2024

12:00 AM

20 Oct , 2023

12:00 AM

12 Oct , 2023

12:00 AM

12 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Aug , 2023

12:00 AM

AGM

Announcement date: 31 Aug , 2023

View Details

11 Jul , 2023

12:00 AM

01 Aug , 2023

12:00 AM

01 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

22 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Jul , 2023

12:00 AM

BookCloser

View Details

05 Sep , 2023

12:00 AM

BookCloser

View Details

26 Oct , 2023

12:00 AM

BookCloser

View Details

Wanbury Ltd News and Update

Image not found
  • 23 February, 2024 |
  • 12:07 AM

Under the "ILS Hospitals" brand, GPT Healthcare Ltd. manages a network of mid-sized full-service hospitals that offer integrated healthcare services, with an emphasis on secondary and tertiary care.

Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Wanbury Ltd SHAREHOLDING SNAPSHOT
26 February , 2024 | 02:43 AM

PROMOTER - TOTAL39.79%

Indian: 30.56%

Foreign: 9.2349%

NON-PROMOTER - TOTAL 60.21%

Institutions: 0.13%

Non-Institutions: 60.08%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Wanbury Ltd FINANCIALS

Wanbury Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Wanbury Ltd

  • N K Puri
  • Independent Director
  • K Chandran
  • Vice Chairman & Whole Time Dir
  • Jitendra J Gandhi
  • Company Sec. & Compli. Officer
  • Pallavi Shedge
  • Independent Director
  • Pravin Dilip Pawar
  • Independent Director

Summary

Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research.The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007. Pursuant to the aforesaid Order of the Honble Bl FR 7,85,557 Equity Shares of face value of Rs. 10/- each of the Company were issued to the Equity Shareholders of DOCL on 17th March, 2008. Similarly, the Pharmaceutical Products of India Limited (PPIL) was merged with the Company effective from April 1, 2006. In terms of the said Scheme of Merger, the Company had issued 5,62,618 Equity Shares of face value of Rs. 10/- each to the Equity Shareholders of PPIL on 27 June, 2007, which got listed on Bombay Stock Exchange Limited and National Stock Exchange Limited respectively.The company entered into a strategic association with Bravo Healthcare Ltd and incorporated Ningxia Wanbury Fine Chemicals Co Ltd to source raw materials from China. It opened its office in Zurich,Switzerland for its CRAMS business and incorporated Wanbury Global FZE in Middle East for carrying out its trading activities in the year... Read More


Reports by Wanbury Ltd


Reports by Wanbury Ltd

Company FAQ

No Record Found